Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$5,997,431
+$214,073 QoQ
Shares Held
16,562
+0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#748
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONS FINANCIAL GROUP INC, /IA/ /ADV holds $42,950,041 across 11 Drug Manufacturers - General names. AMGN ranks #3 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,271 | $13,518,776 | |
| 2 | JNJ |
Johnson & Johnson
|
37,265 | $9,464,192 | |
| 3 | AMGN |
Amgen Inc
This page
|
16,562 | $5,997,431 | |
| 4 | ABBV |
AbbVie Inc.
|
21,335 | $5,368,739 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,911 | $3,072,563 | |
| 6 | PFE |
Pfizer Inc
|
71,165 | $1,713,653 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,741 | $1,137,476 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,753 | $853,174 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,997,431 | 16,562 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,783,358 | 16,437 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,468,040 | 16,706 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4,686,213 | 16,606 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $4,686,539 | 16,785 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,207,869 | 16,716 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,827,313 | 18,521 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,889,998 | 18,280 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $4,343,992 | 13,903 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $3,843,437 | 13,518 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $3,826,633 | 13,286 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,922,820 | 14,596 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,269,910 | 14,728 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,615,854 | 14,957 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,751,549 | 14,284 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $955,019 | 4,237 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,047,406 | 4,305 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,074,889 | 4,445 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $644,539 | 2,865 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $620,512 | 2,918 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $876,037 | 3,594 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $891,237 | 3,582 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $773,910 | 3,366 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $886,764 | 3,489 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $732,817 | 3,107 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $592,579 | 2,923 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||